COMBINING ANTI-CD3 ACTIVATED T-CELLS ARMED WITH ANTI-CD3 X ANTI-HER2 BISPECIFIC ANTIBODY MAY PROVIDE AN ADDITIONAL ANTITUMOR EFFECT AFTER STEM-CELL TRANSPLANT FOR BREAST-CANCER
M. Sen et al., COMBINING ANTI-CD3 ACTIVATED T-CELLS ARMED WITH ANTI-CD3 X ANTI-HER2 BISPECIFIC ANTIBODY MAY PROVIDE AN ADDITIONAL ANTITUMOR EFFECT AFTER STEM-CELL TRANSPLANT FOR BREAST-CANCER, Experimental hematology, 26(8), 1998, pp. 224-224